- With Mayo Clinic diabetes educators
Nancy Klobassa Davidson, R.N., and Peggy Moreland, R.N.
read biographyclose windowBiography of
Nancy Klobassa Davidson, R.N., and Peggy Moreland, R.N.
Nancy Klobassa Davidson and Peggy Moreland
Nancy Klobassa Davidson, R.N., B.S.N, C.D.E
Nancy Klobassa Davidson is a registered nurse who has worked in diabetes education for 17 years. She is a certified diabetes educator (C.D.E.) and is currently in graduate school working on a Master of Science in nursing (M.S.N.) and health care education.Nancy works with adults who have type 1, type 2 and other forms of diabetes. Nancy is coordinator of the Diabetes Unit's intensive insulin therapy program within the Division of Endocrinology, Diabetes, Metabolism, & Nutrition at Mayo Clinic in Rochester, Minn. Nancy has worked extensively with insulin pump therapy and continuous interstitial glucose sensing.
Peggy Moreland, R.N., M.S.N.
Peggy Moreland is a certified diabetes educator (C.D.E.) in the Division of Endocrinology, Diabetes, Metabolism, & Nutrition at Mayo Clinic in Rochester, Minn.Peggy graduated with a Master of Science in Nursing and Health Care Education from the University of Phoenix and is a member of the American Association of Diabetes Educators and the American Diabetes Association. A certified diabetes educator (C.D.E.), Peggy enjoys working with patients to set and achieve diabetes self-management goals.
Latest entries
- Diabetes etiquette: When you don't have diabetes
May 2, 2013
- Coping with diabetes: Helping your loved one
April 24, 2013
- Types of diabetes
March 16, 2013
- Taking diabetes drugs
Feb. 27, 2013
- Insulin or medication?
Feb. 13, 2013
Free
E-newsletter
Subscribe to Housecall
Our weekly general interest
e-newsletter keeps you up to date
on a wide variety of health topics.
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Living with diabetes blog
-
May 1, 2012
Type 2 diabetes medications
By Nancy Klobassa Davidson, R.N., and Peggy Moreland, R.N.
New pharmaceutical company research is leading to an influx of new drug classifications for type 2 diabetes in the United States. The diabetes education department at Mayo Clinic, Rochester, Minn., is having difficulty keeping the patient education brochure for oral/injectable diabetes medications current. As of right now, 10 classifications of diabetes drugs (not including insulin) exist. In addition, there are diabetes combination medications available, as well as one drug that combines cholesterol medication with diabetes medication in one pill.
What's interesting is that these new classifications target specific body systems that can affect type 2 diabetes control. Some of these medications target the brain, pancreas, liver, stomach, intestines and muscles. The number of systems these medications target illustrates the complexity of the disease.
One important consideration if you're deciding on a medication is the cost. When a drug company develops a new drug, the Food and Drug Administration (FDA) grants them a patent to market the drug for a set amount of time. When the drug patent expires, it becomes a generic drug, and other companies are able to manufacture it, which typically reduces the price. With the current increase in new drug competition, the generics are even cheaper. FDA regulations are designed to promote a balance between new drug innovation and the generic drug competition.
When your doctor prescribes a new diabetes medication for you, ask him or her how it works and how effective it is at controlling your diabetes. Of course, you still need to do your part of the diabetes management (diet, exercise, and properly taking medication), too. Also, ask the provider the estimated cost of the medication and if there is a comparative generic drug that would work for you. Generic drugs can save you money.
Have a good week.
Regards,
Nancy
19 comments posted
Share on:
19 comments posted